Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Neuropharmacology

• Publication date

  2000-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0028-3908(99)00271-3PMID 10699452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of aniracetam on impaired sleep patterns in stroke‐prone spontaneously hypertensive rats

  2000cited by this paper
• Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

  1999cited by this paper
• Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam.

  1999cited by this paper
• Neurotrophins and depression.

  1999cited by this paper
• Metabotropic glutamate receptor agonist (1S,3R-ACPD) increased frontal cortex dopamine release in aged but not in young rats.

  1998cited by this paper
• Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia

  1998cited by this paper
• Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam

  1998cited by this paper
• Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5‐dihydroxyphenylglycine

  1998cited by this paper
• Nerve growth factor and brain‐derived neurotrophic factor increase neurotransmitter release in the rat visual cortex

  1998cited by this paper
• LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats

  1998cited by this paper
• Cell body infusions of brain-derived neurotrophic factor increase forebrain dopamine release and serotonin metabolism determined with in vivo microdialysis.

  1998cited by this paper
• Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.

  1998cited by this paper
• Pharmacokinetics of aniracetam and its metabolites in rats.

  1998cited by this paper
• Activation of non-NMDA receptors stimulates acetylcholine and GABA release from dorsal hippocampus: a microdialysis study in the rat.

  1998cited by this paper
• Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam.

  1998cited by this paper
• Treatment of insomnia by concomitant therapy with Zopiclone and Aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease

  1998cited by this paper
• Aniracetam for treatment of patients with progressive supranuclear palsy.

  1997cited by this paper
• The effects of dietary sodium on hypertension and stroke development in female stroke-prone spontaneously hypertensive rats.

  1997cited by this paper
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper
• ANIRACETAM AMELIORATES IMPAIRED PRE- AND POST-SYNAPTIC CHOLINERGIC INDICES IN GERBIL HIPPOCAMPUS INDUCED BY TRANSIENT FOREBRAIN ISCHEMIA

  1997cited by this paper
• Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice.

  1997cited by this paper
• NMDA and Kainate‐evoked Release of Nitric Oxide and Classical Transmitters in the Rat Striatum: In Vivo Evidence that Nitric Oxide May Play a Neuroprotective Role

  1996cited by this paper
• A metabotropic glutamate receptor agonist regulates neurotrophin messenger RNA in rat forebrain.

  1996cited by this paper
• Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats.

  1996cited by this paper
• Activation of Multiple Metabotropic Glutamate Receptor Subtypes Prevents NMDA‐induced Excitotoxicity in Rat Hippocampal Slices

  1996cited by this paper
• Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

  1996cited by this paper
• Metabotropic glutamate receptors: novel targets for drug development.

  1995cited by this paper
• Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats.

  1994cited by this paper
• Novel functions for subtypes of metabotropic glutamate receptors.

  1994cited by this paper
• Clinical Experience with Aniracetam in the Treatment of Senile Dementia of the Alzheimer’s Type and Related Disorders

  1993cited by this paper
• Glutamate receptor agonists enhance the expression of BDNF mRNA in cultured cerebellar granule cells.

  1993cited by this paper
• Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization study

  1993cited by this paper
• Localization of trkB mRNA in postnatal brain development

  1993cited by this paper
• Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat.

  1993cited by this paper
• Attenuation of Excitatory Amino Acid Toxicity by Metabotropic Glutamate Receptor Agonists and Aniracetam in Primary Cultures of Cerebellar Granule Cells

  1993cited by this paper
• Pharmacology of Aniracetam

  1993cited by this paper
• Human Pharmacokinetics of Aniracetam

  1993cited by this paper
• Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: An in situ hybridization study in adult and developing rat

  1992cited by this paper
• Metabotropic Glutamate Receptor Activation Produces Extrapyramidal Motor System Activation That Is Mediated by Striatal Dopamine

  1992cited by this paper
• BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease.

  1991cited by this paper
• The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior.

  1990cited by this paper
• A family of AMPA-selective glutamate receptors.

  1990cited by this paper
• Human reticular formation: Cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons

  1989cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer’s Disease

  2024influential citation
• Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study *

  2012cites this paper
• Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior.

  2007cites this paper
• Aniracetam: its novel therapeutic potential in cerebral dysfunctional disorders based on recent pharmacological discoveries.

  2006cites this paper
• Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats.

  2004cites this paper
• Panel 2 : Licensed indications of piracetam in Europe and the USA Myoclonus

  2004cites this paper
• Actions of Group I and Group II metabotropic glutamate receptor ligands on 5-hydroxytryptamine release in the rat cerebral cortex in vivo: differential roles in the regulation of central serotonergic neurotransmission.

  2003cites this paper
• Cholinergic and dopaminergic mechanisms involved in the recovery of circadian anticipation by aniracetam in aged rats.

  2002cites this paper
• Aniracetam attenuates apoptosis of astrocytes subjected to simulated ischemia in vitro.

  2002cites this paper
• Metabotropic glutamate receptors in the hippocampus and nucleus accumbens are involved in generating seizure-induced hippocampal gamma waves and behavioral hyperactivity.

  2002cites this paper
• Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder.

  2002cites this paper
• Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats.

  2001cites this paper
• Antidepressant-like effects of aniracetam in aged rats and its mode of action

  2001cites this paper
• Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.

  2001cites this paper
• Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP.

  2001cites this paper
• Pyrrolidone derivatives.

  2001cites this paper
• Aniracetam restores motivation reduced by satiation in a choice reaction task in aged rats.

  2001cites this paper
• Recovery of diminished mealtime-associated anticipatory behavior by aniracetam in aged rats.

  2000cites this paper